About RethinkMushrooms

Who We Are

RethinkMushrooms is an independent mushroom science education platform. We are not anti-mushroom. We are not pro-mushroom. We are pro-evidence.

Founded in 2026, RethinkMushrooms exists because the public conversation about mushrooms is fragmented. The supplement industry tells you mushrooms are miracle compounds. Skeptics dismiss them entirely. Neither is giving you the full picture. We exist to fill that gap with peer-reviewed evidence, transparent methodology, and editorial independence.

RethinkMushrooms is not affiliated with any mushroom company, supplement brand, advocacy group, government agency, or trade organization. We are an independent editorial operation with a single mission: give people the science they need to make informed decisions.

Our Expertise

RethinkMushrooms content is produced by the RethinkMushrooms Research Team — a dedicated editorial operation focused exclusively on translating mushroom science into accessible, accurate public health education. Our editorial process involves systematic literature review across five core domains:

• Mycology — fungal biology, species identification, bioactive compound profiles, cultivation science, and taxonomy
• Medicinal mushrooms — reishi, lion's mane, chaga, cordyceps, turkey tail, maitake, and other species studied for therapeutic potential
• Immunology (beta-glucans) — polysaccharide immunomodulation, beta-glucan receptor binding, innate immune activation, and clinical immunology research
• Neuroscience (lion's mane, psilocybin) — neurogenesis, nerve growth factor stimulation, psychedelic-assisted therapy research, and cognitive enhancement studies
• Public health — safety profiles, regulatory considerations, contamination risks, quality control, and vulnerable population considerations

Our systematic literature review draws from journals including Journal of Ethnopharmacology, Mycologia, International Journal of Medicinal Mushrooms, PLOS ONE, Journal of Fungi, Frontiers in Pharmacology, Food Chemistry, Nutrients, and Journal of Agricultural and Food Chemistry.

Our Database

RethinkMushrooms maintains a comprehensive publicly accessible mushroom research database. Every study in our database is tagged, rated for evidence strength, classified by study type, and linked to relevant articles. Our research database is freely accessible and searchable by topic, evidence strength, and study type. Read more about our evidence methodology.

Editorial Independence

Our credibility depends on our independence. We guard it carefully.

• No mushroom industry funding. We do not accept funding, grants, sponsorships, or financial support of any kind from mushroom companies, supplement brands, or mushroom-adjacent businesses.
• No mushroom advertising. We do not display advertisements from mushroom companies or supplement brands. We do not accept sponsored content.
• No affiliate relationships. We do not earn commissions or referral fees from any mushroom product or related service. We have no affiliate links.
• Evidence-driven content. Every editorial decision is driven by the research. We cover both the potential benefits and the documented risks of mushroom use with equal rigor and transparency.

Our Methodology

Every article published on RethinkMushrooms follows a multi-stage editorial pipeline designed to meet the highest standards of health science communication:

1. Research and source identification. Systematic literature review across PubMed, Google Scholar, and journal databases. Relevant studies pulled from our verified citation library.
2. Drafting with inline citations. Articles composed with every factual claim tied to a named, verifiable source during the writing process — not added after the fact.
3. Scientific accuracy review. All claims cross-referenced against original source studies. Numbers, percentages, sample sizes, and methodology descriptions verified for accuracy.
4. Preflight verification. Automated checks confirm formatting consistency, metadata completeness, structural integrity, and schema validation.
5. Publication with version tracking. Every article published with both datePublished and dateModified timestamps. All substantive changes reflected in modification dates.

Evidence strength is rated transparently using a three-tier system: well-established, moderate, and preliminary. Study limitations are always noted. When the evidence is mixed or uncertain, we say so. Read the full details in our evidence methodology and editorial policy.

What Makes Us Different

We are neither pro-mushroom nor anti-mushroom. We are pro-evidence.

• We do not cherry-pick studies that support a particular viewpoint. When a finding supports mushroom benefits, we report it. When a finding identifies risks, we report that too.
• We do not use phrases like “studies show” without naming the specific study. Every claim names author(s), year, and journal.
• We distinguish between well-established findings and preliminary research. We do not present single pilot studies as settled science.
• We report honest uncertainty. When we do not know something, we say “the research has not established this” rather than speculating.
• Our research database is freely accessible. You can verify every claim we make by looking up the named study yourself.

Corrections and Accountability

We welcome corrections. If you find an error in any article or study summary — a misquoted statistic, an outdated finding, a broken source reference, or any other inaccuracy — we want to know about it.

• Email corrections to corrections@rethinkmushrooms.com
• We review all submissions and respond within 7 days
• All corrections are logged with transparent versioning
• Every article displays both datePublished and dateModified
• We do not silently alter published content — substantive changes are always reflected in the modification date

What We Cover

Our articles and research pillars span the full spectrum of mushroom science:

• Medicinal mushrooms — reishi, lion's mane, chaga, cordyceps, turkey tail, maitake, and other species with documented therapeutic research
• Beta-glucans and immunology — what the evidence actually supports for polysaccharide-mediated immune modulation and clinical applications
• Safety and quality — contamination risks, heavy metal testing, fruiting body vs. mycelium distinctions, and regulatory landscape
• Psilocybin research — clinical trials for depression, PTSD, addiction, and end-of-life anxiety, including regulatory developments
• Neuroscience — lion's mane nerve growth factor research, neurogenesis, cognitive enhancement, and neuroprotection studies
• Functional mushrooms — adaptogenic properties, exercise performance, gut health, and metabolic research
• Specific populations — age considerations, contraindications, drug interactions, and population-specific research

Get in Touch

Have a question, correction, or topic suggestion? We would love to hear from you.

• General inquiries: hello@rethinkmushrooms.com
• Corrections and error reports: corrections@rethinkmushrooms.com

Medical Disclaimer

RethinkMushrooms provides educational content only. Nothing on this site constitutes medical advice, diagnosis, or treatment. We are not a healthcare provider and do not provide clinical services. Always consult a qualified healthcare provider before making decisions about mushroom supplement use, particularly if you have a medical condition or take prescription medications. Read our full medical disclaimer.